FluoretiQ

FluoretiQ is developing a rapid-diagnostic technology platform called NANOPLEX to identify and enumerate bacteria in 15 minutes. NANOPLEX uses species-selective probes and a quantum-enhanced fluorometer to rapidly identify the bacterial strains present in patient samples 100 times faster than current lab-based techniqu

FluoretiQ is active in the medical equipment manufacturing space based in Bristol, England, GB, founded in 2017.

Profile

FluoretiQ is developing a rapid-diagnostic technology platform called NANOPLEX to identify and enumerate bacteria in 15 minutes. NANOPLEX uses species-selective probes and a quantum-enhanced fluorometer to rapidly identify the bacterial strains present in patient samples 100 times faster than current lab-based techniques without compromising accuracy.

Within the medical equipment manufacturing space, the company focuses on its core offering rather than a broad product line.

The company is recorded as being based in Bristol, England, GB.

It is recorded at the Small private company stage.

The company reports a headcount in the 1-10 range.

Website: fluoretiq.com